Akebia Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Hosts Conference Call to Discuss Recent Business Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Akebia Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Hosts Conference Call to Discuss Recent Business Highlights

Akebia Therapeutics (AKBA) Misses Q4 EPS by 32c

March 10, 2020 7:59 AM EDT

Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.79), $0.32 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $69.56 million versus the consensus estimate of $93.15 million.

For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.

... More